Taner Dogan

551 total citations
7 papers, 311 citations indexed

About

Taner Dogan is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Taner Dogan has authored 7 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Taner Dogan's work include Melanoma and MAPK Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Ubiquitin and proteasome pathways (2 papers). Taner Dogan is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Ubiquitin and proteasome pathways (2 papers). Taner Dogan collaborates with scholars based in United States, Germany and Switzerland. Taner Dogan's co-authors include Tripat Kaur Oberoi‐Khanuja, Krishnaraj Rajalingam, Christiaan Karreman, Gregory S. Harms, Klaus P. Hoeflich, Mirko Hekman, Emad S. Alnemri, Ulf R. Rapp, Fei Su and Nicholas van Bruggen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Taner Dogan

6 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taner Dogan United States 5 274 91 57 49 45 7 311
Markus Schick Germany 11 209 0.8× 107 1.2× 39 0.7× 34 0.7× 41 0.9× 24 320
Linda Chee United States 7 266 1.0× 67 0.7× 46 0.8× 30 0.6× 45 1.0× 13 342
Romain M. Larive France 11 234 0.9× 88 1.0× 51 0.9× 40 0.8× 33 0.7× 18 324
Thomas S.K. Gilbert United States 12 265 1.0× 104 1.1× 54 0.9× 46 0.9× 30 0.7× 16 373
Giulia Franciosa Denmark 11 252 0.9× 82 0.9× 37 0.6× 39 0.8× 44 1.0× 18 341
Alejandro Fernandez-Woodbridge Sweden 6 253 0.9× 62 0.7× 59 1.0× 50 1.0× 25 0.6× 7 349
María del Mar Maldonado Puerto Rico 7 225 0.8× 91 1.0× 80 1.4× 78 1.6× 41 0.9× 13 335
David M. Bolduc United States 10 324 1.2× 78 0.9× 46 0.8× 29 0.6× 25 0.6× 13 371
Tripat Kaur Oberoi‐Khanuja Germany 8 335 1.2× 89 1.0× 59 1.0× 63 1.3× 56 1.2× 9 392
Sreedhar Venkannagari United States 6 341 1.2× 97 1.1× 36 0.6× 37 0.8× 25 0.6× 8 415

Countries citing papers authored by Taner Dogan

Since Specialization
Citations

This map shows the geographic impact of Taner Dogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taner Dogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taner Dogan more than expected).

Fields of papers citing papers by Taner Dogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taner Dogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taner Dogan. The network helps show where Taner Dogan may publish in the future.

Co-authorship network of co-authors of Taner Dogan

This figure shows the co-authorship network connecting the top 25 collaborators of Taner Dogan. A scholar is included among the top collaborators of Taner Dogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taner Dogan. Taner Dogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dogan, Taner. (2020). Communication Strategies in Turkey. Bloomsbury Publishing Plc eBooks.
2.
Dogan, Taner, Florian Gnad, Jocelyn Chan, et al.. (2017). Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle. Journal of Biological Chemistry. 292(35). 14311–14324. 19 indexed citations
3.
Kirkpatrick, Donald S., Daisy Bustos, Taner Dogan, et al.. (2013). Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibition. Proceedings of the National Academy of Sciences. 110(48). 19426–19431. 44 indexed citations
4.
Baudy, Andreas R., Taner Dogan, Klaus P. Hoeflich, et al.. (2012). FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973. EJNMMI Research. 2(1). 22–22. 52 indexed citations
5.
Baudy, Andreas R., Taner Dogan, Judith E. Flores, et al.. (2012). Abstract 911: Vemurafenib FDG-PET preclinical imaging outcomes across BRAF V600E mutant and resistant tumors. Cancer Research. 72(8_Supplement). 911–911. 1 indexed citations
6.
Oberoi‐Khanuja, Tripat Kaur, Taner Dogan, Jennifer C. Hocking, et al.. (2011). IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. The EMBO Journal. 31(1). 14–28. 108 indexed citations
7.
Dogan, Taner, Gregory S. Harms, Mirko Hekman, et al.. (2008). X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nature Cell Biology. 10(12). 1447–1455. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026